Vilya
Latest round
- Series A
Last raised
- Aug 2022
Total raised
- $71M
Investors
- 6
About Vilya
Founded in 2022 by David Baker, Gaurav Bhardwaj, Lance Stewart, Patrick Salveson, Adam Moyer, and Naozumi Hiranuma, and based in California, US, Vilya, Inc. operates as a biotechnology company that creates a new class of drugs that precisely target the biology of disease. In August 2022, Vilya, Inc. The company designs molecular structures with improved drug-like properties that range in size from small molecules to antibodies to create medicines by utilizing machine learning and uncharted chemical space.
Who invested in Vilya
6 investors across 1 round
See all investors in Vilya
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 30, 2022
Amount
$71M
Investors
Questions about Vilya
Who invested in Vilya?
Vilya has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vilya raised?
Vilya has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Vilya last raise money?
Vilya's most recent round on record is a Series A, in Aug 2022.
What does Vilya do?
Founded in 2022 by David Baker, Gaurav Bhardwaj, Lance Stewart, Patrick Salveson, Adam Moyer, and Naozumi Hiranuma, and based in California, US, Vilya, Inc.
Where is Vilya headquartered?
Vilya is headquartered in South San Francisco, US.
Which VCs invest in companies like Vilya?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Vilya's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Vilya? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.